Inventor

SIMOV VLADIMIR

US13 patents

⚠️ This page may combine multiple inventors who share the name “SIMOV VLADIMIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

11 patents

US9657033B2May 23, 2017

Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

MERCK SHARP & DOHME20 citations91

US9266827B2Feb 23, 2016

Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME23 citations91

US10221146B2Mar 5, 2019

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME6 citations83

US9809561B2Nov 7, 2017

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME8 citations83

US9783511B2Oct 10, 2017

Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME9 citations83

US10377768B2Aug 13, 2019

Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME6 citations82

US9663502B2May 30, 2017

2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME12 citations82

US10221142B2Mar 5, 2019

Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof

MERCK SHARP & DOHME3 citations71

US11161854B2Nov 2, 2021

Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME2 citations68

US10745364B2Aug 18, 2020

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

MERCK SHARP & DOHME0 citations51

US11174248B2Nov 16, 2021

Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME0 citations49

MERCK SHARP & DOHME LLC

2 patents

US12030872B2Jul 9, 2024

N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC2 citations69

US12319671B2Jun 3, 2025

1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC0 citations48